Menu Philippe 4

What Happened
Philippe Menu, Chief Medical Officer of SOPHiA GENETICS SA (SOPH), reported sales of a total of 8,125 shares (dispositions) in April 2026, generating approximately $38,403. Transactions listed:

• 2026-04-10: 3,725 shares disposed at a reported average price of $4.68 for $17,441.
• 2026-04-13: 1,000 shares disposed at a reported average price of $4.76 for $4,764.
• 2026-04-13: 3,400 shares disposed at a reported average price of $4.76 for $16,198.
  These were sales (not purchases) and are routine disposals rather than affirmative insider purchases.

Key Details

• Transaction dates and prices: Apr 10 (3,725 @ $4.68), Apr 13 (1,000 @ $4.76; 3,400 @ $4.76). Total shares sold: 8,125; total proceeds: ~$38,403.
• Footnotes indicate the sales were to satisfy tax withholding on RSU vesting (footnote F1) and were made pursuant to a pre‑established Rule 10b5‑1(c) trading plan (footnote F4), i.e., non‑discretionary.
• Reported prices are weighted averages; the filing notes sale prices ranged roughly from $4.61 to $4.88 across the transactions (footnotes F2/F3). The filer can provide per‑trade price breakdown on request.
• Shares owned after the transactions are not specified in the excerpt of the filing provided.
• Filing: Form 4 filed Apr 14, 2026. The filing does not indicate a late filing.

Context
These sales were expressly made to cover tax withholding obligations related to vesting restricted stock units and were executed under a Rule 10b5‑1 plan. Such tax‑withholding sales are common and generally treated as administrative/routine rather than a clear signal about an insider’s view of the company.